John A Ford

Summary

Affiliation: University of East Anglia
Country: UK

Publications

  1. doi request reprint Denosumab for treatment of bone metastases secondary to solid tumours: systematic review and network meta-analysis
    John A Ford
    Health Services Research Unit, University of Aberdeen, Aberdeen, UK
    Eur J Cancer 49:416-30. 2013
  2. pmc The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review
    John A Ford
    Health Services Research Unit, University of Aberdeen, Health Services Building, Aberdeen AB25 2ZD, UK
    BMJ 345:e5182. 2012
  3. doi request reprint Assessing pharmacological interventions for bone metastases: the need for more patient-centered outcomes
    John A Ford
    Health Services Research Unit, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, Scotland, UK
    Expert Rev Clin Pharmacol 5:271-9. 2012
  4. pmc NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium
    John A Ford
    Health Services Research Unit, University of Aberdeen, Aberdeen, UK
    BMJ Open 2:e000671. 2012

Collaborators

Detail Information

Publications4

  1. doi request reprint Denosumab for treatment of bone metastases secondary to solid tumours: systematic review and network meta-analysis
    John A Ford
    Health Services Research Unit, University of Aberdeen, Aberdeen, UK
    Eur J Cancer 49:416-30. 2013
    ..To evaluate the evidence for denosumab for the treatment of bone metastases secondary to solid tumours and, using a network meta-analysis, indirectly compare denosumab with bisphosphonates and best supportive care...
  2. pmc The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review
    John A Ford
    Health Services Research Unit, University of Aberdeen, Health Services Building, Aberdeen AB25 2ZD, UK
    BMJ 345:e5182. 2012
    ..To indirectly compare the effectiveness of ranibizumab and bevacizumab in the treatment of diabetic macular oedema...
  3. doi request reprint Assessing pharmacological interventions for bone metastases: the need for more patient-centered outcomes
    John A Ford
    Health Services Research Unit, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, Scotland, UK
    Expert Rev Clin Pharmacol 5:271-9. 2012
    ..In this article we illustrate the evolution of outcomes used in randomized controlled trials, critically appraising current outcomes used and proposing that more patient-centered outcomes are needed...
  4. pmc NICE guidance: a comparative study of the introduction of the single technology appraisal process and comparison with guidance from Scottish Medicines Consortium
    John A Ford
    Health Services Research Unit, University of Aberdeen, Aberdeen, UK
    BMJ Open 2:e000671. 2012
    ..The STA process has improved the time to publication but not for cancer drugs. The lengthier time for NICE guidance is partly due to measures to provide transparency and the widespread consultation during the NICE process...